Clemente Capasso Selected Research

Carbonic Anhydrases (Carbonic Anhydrase)

12/2022	A comparative study of carbonic anhydrase activity in lymphocytes from colorectal cancer tissues and adjacent healthy counterparts.
6/2022	Continued Structural Exploration of Sulfocoumarin as Selective Inhibitor of Tumor-Associated Human Carbonic Anhydrases IX and XII.
12/2021	Is carbonic anhydrase inhibition useful as a complementary therapy of Covid-19 infection?
10/2021	Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors.
4/2021	Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors.
1/2021	Microbiota, Bacterial Carbonic Anhydrases, and Modulators of Their Activity: Links to Human Diseases?
12/2019	Phaeodactylum tricornutum as a model organism for testing the membrane penetrability of sulphonamide carbonic anhydrase inhibitors.
12/2019	Seeking new approach for therapeutic treatment of cholera disease via inhibition of bacterial carbonic anhydrases: experimental and theoretical studies for sixteen benzenesulfonamide derivatives.
7/2019	Anion Inhibition Profile of the β-Carbonic Anhydrase from the Opportunist Pathogenic Fungus Malassezia Restricta Involved in Dandruff and Seborrheic Dermatitis.
5/2019	Cloning, Purification, and Characterization of a β-Carbonic Anhydrase from Malassezia restricta, an Opportunistic Pathogen Involved in Dandruff and Seborrheic Dermatitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Clemente Capasso Research Topics

Disease

15	Neoplasms (Cancer) 06/2022 - 01/2011
11	Dandruff 12/2020 - 11/2015
9	Malaria 12/2022 - 09/2014
8	Infections 12/2022 - 02/2014
6	Dehydration (Water Stress) 12/2019 - 01/2016
5	Melioidosis 12/2018 - 01/2017
4	Periodontitis 09/2014 - 07/2013
4	Chagas Disease (American Trypanosomiasis) 01/2014 - 02/2013
3	Seborrheic Dermatitis 01/2020 - 05/2019
3	Cholera 12/2019 - 02/2014
3	Reperfusion Injury 11/2015 - 01/2015
2	Carcinogenesis 12/2022 - 12/2014
2	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 01/2021
2	COVID-19 12/2021 - 04/2021
2	Prostatic Neoplasms (Prostate Cancer) 12/2020 - 12/2019
2	Nervous System Diseases (Neurological Disorders) 05/2020 - 12/2015
2	Tularemia 01/2017 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2016 - 01/2011
2	Dental Caries (Decay, Dental) 07/2015 - 06/2015
2	Fatty Liver 01/2015 - 01/2015
2	Pathologic Processes 01/2015 - 01/2015
1	Lung Diseases (Lung Disease) 12/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2021
1	Dysbiosis 01/2021
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2020
1	Phobic Disorders (Phobia) 12/2020
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 12/2020
1	Dermatitis 12/2020
1	Tuberculosis (Tuberculoses) 12/2018
1	Epilepsy (Aura) 01/2017
1	Glaucoma 01/2017
1	Bacterial Infections (Bacterial Infection) 01/2017
1	Kidney Diseases (Kidney Disease) 01/2017
1	Mycoses (Diseases, Fungus) 12/2016
1	Hypoxia (Hypoxemia) 11/2015
1	Communicable Diseases (Infectious Diseases) 08/2014
1	Acute Kidney Injury (Acute Renal Failure) 06/2014
1	Leishmaniasis 09/2013
1	Autoimmune Diseases (Autoimmune Disease) 08/2013

Drug/Important Bio-Agent (IBA)

47	Carbonic Anhydrases (Carbonic Anhydrase)IBA 12/2022 - 02/2013
17	EnzymesIBA 12/2020 - 07/2013
15	SulfonamidesIBA 10/2021 - 02/2013
12	Protein Isoforms (Isoforms)IBA 12/2022 - 09/2013
9	Pharmaceutical PreparationsIBA 06/2022 - 11/2015
6	AnionsIBA 07/2019 - 08/2013
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 02/2014
4	BenzenesulfonamidesIBA 12/2019 - 02/2015
4	Amino Acids FDA Link 12/2018 - 01/2016
3	AcidsIBA 12/2021 - 01/2015
3	Carbonic Anhydrase IXIBA 12/2020 - 01/2017
3	AminesIBA 12/2018 - 03/2016
3	IsoenzymesIBA 07/2018 - 09/2013
3	Antimalarials (Antimalarial Agents)IBA 01/2017 - 01/2016
2	Bicarbonates (Hydrogen Carbonate)IBA 12/2022 - 10/2018
2	Acetazolamide (Diamox)FDA LinkGeneric 12/2021 - 11/2015
2	SLC-0111IBA 04/2021 - 10/2020
2	Proteins (Proteins, Gene)FDA Link 12/2020 - 12/2014
2	Anti-Obesity Agents (Antiobesity Drugs)IBA 05/2020 - 12/2015
2	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 12/2017 - 02/2014
2	Cisplatin (Platino)FDA LinkGeneric 07/2012 - 01/2011
1	Protons (Proton)IBA 12/2022
1	CoumarinsIBA 12/2022
1	AzolesIBA 12/2022
1	Carbon DioxideIBA 12/2022
1	ProdrugsIBA 06/2022
1	quinolineIBA 10/2021
1	quemliclustatIBA 10/2021
1	Monoclonal AntibodiesIBA 10/2021
1	benzofuranIBA 04/2021
1	Antiviral Agents (Antivirals)IBA 04/2021
1	Peptide Hydrolases (Proteases)FDA Link 04/2021
1	Biomarkers (Surrogate Marker)IBA 12/2020
1	Cell-Free Nucleic AcidsIBA 12/2020
1	Molecular Probes (Molecular Probe)IBA 12/2020
1	ElectrolytesIBA 10/2018
1	Carboxylic AcidsIBA 07/2018
1	Ficusin (Psoralen)IBA 07/2018
1	coumarinIBA 07/2018
1	PolyphenolsIBA 01/2018
1	PhenolsIBA 01/2017
1	CosmeticsIBA 01/2017
1	artemisinin (artemisinine)IBA 01/2017
1	imidazothiadiazoleIBA 01/2017
1	LigandsIBA 03/2016
1	Hydro-Lyases (Dehydratases)IBA 01/2016
1	Carbonic Anhydrase IIBA 01/2016
1	SulfonesIBA 02/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2015
1	SolutionsIBA 01/2015
1	Oxygen (Dioxygen)IBA 01/2015
1	Superoxide DismutaseIBA 06/2014
1	Hydroxamic Acids (Hydroxamic Acid)IBA 01/2014
1	sulfamic acid (ammonium sulfamate)IBA 01/2014
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2013
1	Sulfhydryl Compounds (Thiols)IBA 02/2013
1	Therapeutic UsesIBA 07/2012

Therapy/Procedure

4	Therapeutics 12/2021 - 01/2017
1	Immunotherapy 10/2021
1	Drug Therapy (Chemotherapy) 01/2016
1	Liver Transplantation 11/2015